Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA Senate Approves AI Companion Chatbots Safety Bill California’s Senate passed a bill ( SB 243 ) that would require artificial intelligence-powered companion chatbot platforms to remind users...
OR Lawmakers Close to Approving Unemployment for Striking Workers The Oregon House passed a bill ( SB 916 ) that would allow striking workers to receive unemployment benefits for up to 26 weeks. The...
CO Changes Way PBMs Paid Colorado Gov. Jared Polis (D) signed a bill ( HB 1094 ) that, among other things, will allow pharmacy benefit managers, starting in 2027, to only be paid a flat service fee instead...
LA Homeowners Sue Insurers over Inadequate Fire Coverage Victims of the Los Angeles wildfires in January have filed a pair of lawsuits claiming USAA, a Texas-based insurer that serves members of the...
A year ago, after the passage of a couple of strong data privacy laws in Maryland and Vermont, we wondered if states were starting to get tougher on consumer privacy . Even though this issue remains...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
California joined a nationwide movement to tighten restrictions on pharmacy benefit managers with the approval of SB 966 days before adjourning its legislative session on Aug. 31. If signed by Gov. Gavin Newsom (D) the measure will establish licensing requirements for PBMs and require them to report to the state’s Department of Insurance the fees they charge pharmacies and the rebates they receive from drug manufacturers. The bill would also require PBMs to pass along 100% of those rebates to health plans or insurers. (PLURIBUS NEWS, LEXISNEXIS STATE NET)
In 2021, Arkansas became the first state to pass a law requiring pharmaceutical manufacturers that participate in Medicaid to sell drugs to contract pharmacies at a discount under the federal 340B program. Louisiana followed suit in 2023. This year, Kansas (SB 28), Maryland (HB 1056), Mississippi (HB 728), Missouri (SB 751) and West Virginia (SB 325) enacted similar legislation. And other states, including New York (AB 7789), considered similar measures.
The recent legislative actions are pushback against the restriction of 340B drug sales by pharmaceutical companies, which contend the 340B program has expanded beyond its original intent. As of September 2023, 25 drugmakers had done so. (STATELINE)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.